{"name":"Goldfinch Bio, Inc.","slug":"goldfinch-bio-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxONXkwdkpRb1dwaWpXVklxcVZOem9TZXFzeGt6emVMSWlrOXZWR2FFdjk0Tmt6Vl9RSUdJRXItWFNwVnBlLUtRLUNLMXVrblhBaWRPSzA3N0tYOVpkWXhibWNHbjEzclJaNXVDRVA3RnRIOGVneDhIN1FLUmJHQ2lYX240QWJpS25uWEktNnc1TjFMaF8zNDlEYjJPSHBwT1U?oc=5","date":"2026-03-17","type":"pipeline","source":"openPR.com","summary":"Nephrotic Syndrome Treatment Pipeline Shows Strong Momentum as 3+ Pharma Companies in the Race | DelveInsight - openPR.com","headline":"Nephrotic Syndrome Treatment Pipeline Shows Strong Momentum as 3+ Pharma Companies in the Race | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxQeklpU0R2MDl5WXhxSXljaVNpZEFvZTBsN3EwaUtrNG1wV2JpVkRGS0xmaEpCY1RfU0RVb0RKVXdSLUdyXzVUMVYyaHN1bmJIeTRONkx6am9NbzVoNHItR25LSGpJWmlGTFhHSmlLQ1ZuNlFYOE1lY2RXSjluNGxYc3c4VWIwdzNmeGtyQzBPOVc2LWhSQXpzNy1ldDMxaEUwVjg1MXU0YmZCcDF3NGtUc1pkeU1neldDQVU0dUxR?oc=5","date":"2023-02-03","type":"deal","source":"BioCentury","summary":"Feb. 2 Quick Takes: Roche’s pipeline cuts include IPF therapy from Promedior deal - BioCentury","headline":"Feb. 2 Quick Takes: Roche’s pipeline cuts include IPF therapy from Promedior deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxNcnFLZHhlNWhpamJnc3ZodXM1dkRnT3FtZllUZGNoazFONjRLTG5UeHVFS2c3ZE5sOHFRVFhZQ2ZlWk5EY2YzWFZuYXMyRHpIRTlUV3J2RXQwSjJJeWhkN1gtbEZqUUJOSzNfMDg1S3A5c2xTTDRPWFd6a0F6dEFFRkFMYV9JTGQ1aVdKVnJQLS0?oc=5","date":"2023-02-02","type":"deal","source":"BioPharma Dive","summary":"Karuna, hoping to find new brain drugs, buys up a shuttering biotech’s pipeline - BioPharma Dive","headline":"Karuna, hoping to find new brain drugs, buys up a shuttering biotech’s pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwJBVV95cUxOQ2REeDdlN3puQUQzd3FkV3haMTZ2MFdIcmc2aWtoYjBmaFVvS3EzajczZGxUZW5MV282SmxKZjFuemtMRzhMV3JHSTBjU0hFakxBR0M3b0ZHa01RNmhYVWxwZnpuQkhLQmhhNTFxTWdyVzY5SDVTN3A0ajJKZXp5WmQydzZxbVVpdEthM1pDejdxWV9ZMWQxS2djYkZ1MjdJZFB2MEJTZ3JnOGZtdlZYYTFMdWV4eHBEazNNYnRVd3VCZUNaU2plUElTSk1relQ0SVJtRXE4YWRNeS1rdVNTRjVLdHkyblVNRU1UY3hXZFBvVFNPRENqT2hjeXRQOXZBNVl5SjdhWmdHODlpZ01R?oc=5","date":"2023-02-02","type":"deal","source":"Business Wire","summary":"Karuna Therapeutics Announces Exclusive Global License Agreement for Goldfinch Bio’s Investigational TRPC4/5 Product Candidates - Business Wire","headline":"Karuna Therapeutics Announces Exclusive Global License Agreement for Goldfinch Bio’s Investigational TRPC4/5 Product Can","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxPeGVkMTFQMWhFNUt1el9fNUdvTi1aWWp4OUJORkNoNWVUWmN3bG1QV3l5S0xmUXhKWjhPMlNtQWZIVU5xRmg0dWNyVDNqOEtoRXRnaS1LNG1yT1ZBVHBmamdRWjNaSktiOGNSZWRzdmwwNndlX2c1blBHVVhYZGFzRmFqVVh6VnlGaGw3b2dTc2swZTRKT05qc2VEYW4xUXFieTNVRGZ1R0l4NjJuSVdLRQ?oc=5","date":"2023-01-27","type":"pipeline","source":"Fierce Biotech","summary":"Goldfinch Bio falls from the sky after failing to find a path forward for kidney treatments - Fierce Biotech","headline":"Goldfinch Bio falls from the sky after failing to find a path forward for kidney treatments","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxQVnNkLWl4T01mMW8xX0RXZm5CWFh5dV9UMk5HR1hxM3ZMTFE3WklvQ1FKQVUyVzBieVQxbVYxaktPV2lLQWEtSlBPUWhMd3Y2M0NRMU5iM3Z4NjBXbWw0bHV6S0MwbmVWQ1JwM1dwVzVveTFBQ29RMk51SlVwdjdTMDJNMVNWWUpVZlpuOXRydm9KRlU?oc=5","date":"2022-10-19","type":"pipeline","source":"citybiz","summary":"Senda Biosciences Expand Executive Leadership Team - citybiz","headline":"Senda Biosciences Expand Executive Leadership Team","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AJBVV95cUxQN3l4dURGc0lWLUgxRTh0bzl6enpMMzhFdTY4bmpDNDBQeTJxVzBTTHN3VTV1V1dxSkFlWkF5eU9SeUNOTkNpaldFNDM3bzI5TkZEWVhvQWJ6Nk42UzNhdkpSQ2VUQnBvSUZQR25sYU9FS01vTmxVdEloRk1yLU1BMHdZOWoxLVhYd3UzN05QaWV0ODR4NGEwWUdXUzRJeFk5NFhoc29rTzUyYVpQUTNpRWdHaG5zZS1rdDhHRVRwUElRWFZkQ0N6LXhFM0QzdTJpMFphMjFINWRYdFd1RFNiOHB0aTl1TmdZY2J2cGVNXzdKQjgxQzNzalpoMGRRR0JqRXpPcmNZeXpBNjVrLTlrajh0SkZUWXdHSWFiZDJnaWx3M1lGR0N3UFR4a1oxLUdTanFkckdxdUFtWHZBbVFwWXlSaC10VjZIWGg0bVFDWnV1UW1aM1FSYg?oc=5","date":"2022-02-28","type":"trial","source":"Business Wire","summary":"Goldfinch Bio Announces Positive Preliminary Data from Phase 2 Clinical Trial Evaluating GFB-887 as a Precision Medicine for Patients with Focal Segmental Glomerular Sclerosis (FSGS) - Business Wire","headline":"Goldfinch Bio Announces Positive Preliminary Data from Phase 2 Clinical Trial Evaluating GFB-887 as a Precision Medicine","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxQNVc4VG5yNS1hMHRPNGJQQUdpVk9DYWxWMldGR2E5VjYtTFNFc2duVjEzWHg4dmxBekNXWWFaRHdMdFowSkhYbnRmZzJyeXU3Mjhab0J5YUZpU1EzWWJRVWYzQWVxV2NFMU95cFFVbnhpeENaTGs5bzBHT3VwQmxvUndkX1ZMMEUxVUJRaXd6UWxNZ3h3empDdzZaOHFMcEpUeHZyeXU3YXVzdlFIUG1ZVWJaQzk2QQ?oc=5","date":"2022-01-24","type":"pipeline","source":"citybiz","summary":"Goldfinch Bio Announces Appoints Edwin J. Tucker, M.D., as Chief Medical Officer - citybiz","headline":"Goldfinch Bio Announces Appoints Edwin J. Tucker, M.D., as Chief Medical Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxOeGpUOFozclZ2d25BVjFyNTF2NjgxWG4yXzVOUW01RW5VSXk4Sld3YmljcmRIcHZrZjlvekFNVDRzVXNUVkdWZDI1WmtTdVhtbzlodTNjWk9hWVMweWxTMVlKeUdiVkk4Y0pvQVMybmdGT0M3TGNTMm14SXZQUnA2ZVB3?oc=5","date":"2020-09-28","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech's 2020 Fierce 15 - Fierce Biotech","headline":"Fierce Biotech's 2020 Fierce 15","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxPeGRDZUNGY21jdXNyNDFocEpadE1WQng4UlFxMWdWSkN3NzhFZnlaV21RbWRxemRpZHBVSHpWWTVob3lrYUdqOWVlSVRYWkVOWDFIX3JFQ3Vid2t6dGl3ejhDeEJnZDYyeTdjWHF5TlhVNzV1bW43bHdQZHJzWTZuQmNTaE1NWWR4MXJDZ1JPUWk4R2ZrVWFDOTVPWQ?oc=5","date":"2018-12-12","type":"pipeline","source":"BioSpace","summary":"Frank S. Czerwiec, M.D., Ph.D. joins Goldfinch Bio as Chief Medical Officer - BioSpace","headline":"Frank S. Czerwiec, M.D., Ph.D. joins Goldfinch Bio as Chief Medical Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE1xcWphMi1sY0NZb1NCMEkxWjJmTDd3NENRaGVrRklOQV9nLXY5LTJKMDlZZXJRZUFqYUUtNmlva2JUaC1xeDA4Wkc0dDhuMm1TWUdybVhQSmlEUjc2UkpxMmZTVG5kS1VrMzBfaEtIRGRpMER2T1NSRg?oc=5","date":"2018-04-05","type":"trial","source":"VUMC News","summary":"Nashville Biosciences created to leverage wealth of data - VUMC News","headline":"Nashville Biosciences created to leverage wealth of data","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPcVNLRHIwendjRW9nNE5tajJnZWxiSC1vV0h2ZFRVNXRzYTRZdFBIOWdaZ3lfTVJFek04RlBUMHpHSmRMUnE1Z1JIQV85N2l6RUFWMFJOQWhfd0JBQlROdU01aVhJbUVWN0xzY1pZQW5KZzR0VVpGUFNzZEg2bkYwY3NOX0JfVWtUazJR?oc=5","date":"2017-01-10","type":"pipeline","source":"Massachusetts Biotechnology Council","summary":"An Open Letter to the BioPharma Community - Massachusetts Biotechnology Council","headline":"An Open Letter to the BioPharma Community","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}